Notice of Registration - 2012
[Federal Register Volume 77, Number 219 (Tuesday, November 13, 2012)]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-27567]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
By Notice dated July 17, 2012, and published in the Federal
Register on July 26, 2012, 77 FR 43862, Nektar Therapeutics, 1112
Church Street, Huntsville, Alabama 35801, made application by letter to
the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of Fentanyl (9801), a basic class of controlled substance
listed in schedule II.
The company plans to manufacture the listed controlled substance in
support of product development.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Nektar Therapeutics to manufacture the listed basic class of controlled
substance is consistent with the public interest at this time. DEA has
investigated Nektar Therapeutics to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems; verification of the company's compliance with state and local
laws; and review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33,
the above named company is granted registration as a bulk manufacturer
of the basic class of controlled substance listed.
Dated: November 5, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
[FR Doc. 2012-27567 Filed 11-9-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).